Free Trial

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors

GBX 1,518.70
+7.60 (+0.50%)
(As of 07/12/2024 ET)

FBT vs. SGE, AVV, AVST, SOPH, KNOS, PRSM, KAPE, TRST, GBG, and LTG

Should you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include The Sage Group (SGE), AVEVA Group (AVV), Avast (AVST), Sophos Group plc (SOPH.L) (SOPH), Kainos Group (KNOS), Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), GB Group (GBG), and Learning Technologies Group (LTG). These companies are all part of the "software - application" industry.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and The Sage Group (LON:SGE) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

The Sage Group has a consensus price target of GBX 1,183, indicating a potential upside of 11.24%. Given The Sage Group's higher probable upside, analysts plainly believe The Sage Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
The Sage Group
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation both had 1 articles in the media. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 1.53 beat The Sage Group's score of 1.02 indicating that First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
The Sage Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

The Sage Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than The Sage Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation£870.31K5,156.26N/A-£1.10-1,380.64
The Sage Group£2.25B4.72£267M£0.264,090.38

The Sage Group has a net margin of 11.87% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. The Sage Group's return on equity of 22.31% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.

Company Net Margins Return on Equity Return on Assets
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A
The Sage Group 11.87%22.31%7.58%

68.3% of The Sage Group shares are owned by institutional investors. 0.7% of The Sage Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

The Sage Group received 451 more outperform votes than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation when rated by MarketBeat users. However, 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote while only 45.01% of users gave The Sage Group an outperform vote.

CompanyUnderperformOutperform
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes
72
66.67%
Underperform Votes
36
33.33%
The Sage GroupOutperform Votes
523
45.01%
Underperform Votes
639
54.99%

Summary

The Sage Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 11 of the 14 factors compared between the two stocks.

Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBT vs. The Competition

MetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON Exchange
Market Cap£4.49B£2.38B£23.61B£1.57B
Dividend YieldN/A2.97%2.67%11.27%
P/E Ratio-1,380.64859.96210.921,844.43
Price / Sales5,156.264,952.14564.65357,771.05
Price / Cash3.5418.6932.2835.04
Price / Book799.3213.487.032.70
Net IncomeN/A£7.82M£633.29M£160.44M
7 Day Performance4.39%0.52%3.07%75.12%
1 Month PerformanceN/A0.69%2.84%72.89%
1 Year Performance5.31%56.72%11.97%93.71%

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGE
The Sage Group
1.2152 of 5 stars
1.22 / 5 stars
GBX 1,063.50
+1.0%
GBX 1,183
+11.2%
+16.2%£10.62B£2.25B4,090.3811,326Dividend Increase
Positive News
AVV
AVEVA Group
0 of 5 stars
0.00 / 5 stars
N/AN/AN/A£9.72B£1.26B-154.766,250Gap Up
AVST
Avast
0 of 5 stars
0.00 / 5 stars
GBX 716.60
-0.5%
N/A+0.0%£7.49B£940.10M3,115.651,800High Trading Volume
SOPH
Sophos Group plc (SOPH.L)
0 of 5 stars
0.00 / 5 stars
GBX 580.40
+1.0%
N/A+0.0%£2.99B£726.90M341.413,381
KNOS
Kainos Group
0.1972 of 5 stars
0.20 / 5 stars
GBX 1,082
+0.7%
GBX 1,165
+7.7%
-16.8%£1.36B£382.39M2,774.363,028News Coverage
PRSM
Blue Prism Group
0 of 5 stars
0.00 / 5 stars
GBX 1,274
flat
N/A+0.0%£1.24B£167.30M-23.681,025High Trading Volume
KAPE
Kape Technologies
0 of 5 stars
0.00 / 5 stars
N/AN/AN/A£1.22B£623.48M1,900.00850Gap Down
TRST
Trustpilot Group
0.4006 of 5 stars
0.40 / 5 stars
GBX 232.50
+4.5%
GBX 225
-3.2%
+231.9%£965.32M£176.36M23,250.00900Analyst Forecast
News Coverage
GBG
GB Group
0.4318 of 5 stars
0.43 / 5 stars
GBX 352.60
+0.2%
GBX 356.67
+1.2%
+48.2%£890.67M£277.35M-511.011,183Positive News
LTG
Learning Technologies Group
1.999 of 5 stars
2.00 / 5 stars
GBX 87.30
+2.7%
GBX 107.50
+23.1%
+8.0%£690.42M£562.31M2,182.505,001Positive News
Gap Up
High Trading Volume

Related Companies and Tools

This page (LON:FBT) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners